Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

1.84USD
17 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.84
Open
$1.82
Day's High
$1.86
Day's Low
$1.80
Volume
22,598
Avg. Vol
43,061
52-wk High
$4.35
52-wk Low
$1.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.127
Jun '18 0.00 -0.063
Mar '18 0.00 -0.107
Dec 0.00 -0.093
FY 2017 Sep '17 0.00 -0.122
Jun '17 0.00 -0.087
Mar '17 0.00 -0.038
Dec 0.00 -0.082
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Mar-19 1 -0.11 -0.11 -0.11 --
Quarter Ending Jun-19 1 -0.12 -0.12 -0.12 --
Year Ending Sep-19 1 -0.45 -0.45 -0.45 -0.48
Year Ending Sep-20 1 -0.49 -0.49 -0.49 -0.48
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 1.01 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 7.57 10.16 5.27
Price to Tangible Book (MRQ) 7.57 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 24.62 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -38.62 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 9.14 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 17.09 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.00 12.88
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.43 8.32
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.62
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,650,742 844,239,900
Net Income/Employee (TTM) -1,481,687 652,581 100,064,185
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.28 6.45 11.08
Return on Assets - 5 Yr. Avg. -173.84 5.52 12.21
Return on Investment (TTM) -95.21 8.99 14.48
Return on Investment - 5 Yr. Avg. -289.36 6.85 15.88
Return on Equity (TTM) -95.21 10.13 15.99
Return on Equity - 5 Yr. Avg. -476.42 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Anavex Life Sciences Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.66 -12.77 33 99
13 Week -21.31 -25.14 35 95
26 Week -28.16 -33.62 46 98
52 Week 17.27 -0.60 99 72
YTD 6.31 -6.64 97 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.72%
# of Holders: 58
Total Shares Held: 8,253,970
3 Mo. Net Change: 2,491
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.